07:30 - 09:00		Free Paper Presentation 9
Meeting Room 310		HIV/AIDS
07:30 - 09:00		Free Paper Presentation 10
Meeting Room 311A		Gastro-intestinal Infection and Paediatrics
07:30 - 09:00		Free Paper Presentation 11
Meeting Room 311B		Viral Hepatitis and End Stage Liver Disease
09:15 - 10:45		Concurrent Session 13
Meeting Room 310		WHO Collaboration Lab - HIV
09:15 - 10:45		Concurrent Session 14
Meeting Room 311A		Viral Hepatitis and Liver Cancer
CS 14.1	09:15 - 09:35	The risk of hepatocellular carcinoma in HCV-related chronic hepatitis
		Masao Omata, Tokyo
CS 14.2	09:35 - 09:55	Risk assessment of HBV-related HCC development using liver stiffness measurement
		Seung Up Kim, Seoul
CS 14.3	09:55 - 10:15	The potential of genetically modified T cells to prevent HBV related HCC
		Adam J. Gehring, Singapore
CS 14.4	10:15 - 10:35	Translational study of HBV infection related with hepatocellular carcinomas
		Fengmin Lu, Beijing
	10:35 - 10:45	Discussion
10:45 - 11:15		Poster Session / Coffee Break
11:15 - 12:45		Concurrent Session 15
Meeting Room 310		Detection and Clinical Significance of Virla Infection
	11:15 - 11:35	CMV in transplant recipients
		Ban Hock Tan, Singapore
	11:35 - 11:55	EV71
		Tianwei Lin, Xiamen
	11:55 - 12:15	More and more coronaviruses after the SARS epidemic: human coronavirus HKU1 and other coronaviruses
		Patrick C.Y. Woo, Hong Kong
	12:15 - 12:35	Herpesvirus
		Wenhui Lun, Beijing (TBC)
	12:35 - 12:45	Discussion
11:15 - 12:45		Concurrent Session 16
Meeting Room 311A		End Stage Liver Disease and Complications
CS 16.1	11:15 - 11:35	Management of the complications of liver cirrhosis
		Hong You, Beijing
CS 16.2	11:35 - 11:55	Improving survival in patients with decompensated cirrhosis
		Deepak N. Amarapurkar, Mumbai
CS 16.3	11:55 - 12:15	New concept in nomenclature, classification and diagnosis of liver failure
		Yuming Wang, Chongqing
CS 16.4	12:15 - 12:35	Treatment strategy developments of hepatitis B with liver failure
		Zhiliang Gao, Guangzhou
	12:35 - 12:45	Discussion